Response to Interferon Therapy in 95 Patients
| Responses . | Treated . | Untreated . | P Value . |
|---|---|---|---|
| . | n = 45 . | n = 50 . | . |
| During treatment | |||
| Primary responders | 20 (44%) | 2 (4%) | <.002 |
| Breakthroughs | 5 (11%) | 0 | <.05 |
| Nonresponders | 25 (56%) | 48 (96%) | <.001 |
| End of treatment | |||
| Complete responders | 12 (27%) | 0 | <.001 |
| End of follow-up | |||
| Complete responders | 6 (13%) | 0 | <.01 |
| Responses . | Treated . | Untreated . | P Value . |
|---|---|---|---|
| . | n = 45 . | n = 50 . | . |
| During treatment | |||
| Primary responders | 20 (44%) | 2 (4%) | <.002 |
| Breakthroughs | 5 (11%) | 0 | <.05 |
| Nonresponders | 25 (56%) | 48 (96%) | <.001 |
| End of treatment | |||
| Complete responders | 12 (27%) | 0 | <.001 |
| End of follow-up | |||
| Complete responders | 6 (13%) | 0 | <.01 |
Complete response means normal transaminase values and negative RT-PCR for HCV-RNA.